CORDIS
EU research results

CORDIS

English EN
European Vaccine Research and Development Infrastructure

European Vaccine Research and Development Infrastructure

Objective

TRANSVAC2 is the follow-up project to its successful predecessor project TRANSVAC, the European Network of Vaccine Research and Development funded under FP7. The TRANSVAC2 consortium comprises a comprehensive collection of leading European institutions that propose to further advance with the previous initiative towards the establishment of a fully operational and sustainable European vaccine R&D infrastructure. TRANSVAC2 will support innovation for both prophylactic and therapeutic vaccine development based on a disease-overarching and one-health approach, thereby optimising the knowledge and expertise gained during the development of both human and animal vaccines. This will be achieved by bridging the translational gap in biomedical research, and by supporting cooperation between public vaccine R&D institutions of excellence, related initiatives and networks in Europe, and industrial partners. TRANSVAC2 will complement and integrate with existing European research infrastructures in both the public and private sectors. TRANSVAC2 will function as leverage and innovation catalyst between all stakeholders involved in vaccine R&D in Europe and -by providing integrated and overarching vaccine R&D services- will contribute to the development of effective products to address European and global health challenges, to controlling the burden and spread of infectious diseases, and reinforce the economic assets represented by vaccine developers in Europe.
The impact of TRANSVAC2 will be maximised by two external advisory bodies. An independent Scientific & Ethics Advisory Committee will provide recommendations surrounding scientific-technical and ethical issues, whereas the coordination of TRANSVAC2 with other related initiatives and the further promotion of the long-term stability of a European vaccine R&D infrastructure will be supported by a Board of Stakeholders comprising representatives of policy and decision makers, industry associations and European infrastructures.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

EUROPEAN VACCINE INITIATIVE EWIV

Address

Vossstrasse 2 Geb 4040
69115 Heidelberg

Germany

Activity type

Research Organisations

EU Contribution

€ 1 254 147,01

Participants (25)

Sort alphabetically

Sort by EU Contribution

Expand all

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Germany

EU Contribution

€ 490 307,51

STATENS SERUM INSTITUT

Denmark

EU Contribution

€ 601 445

SCLAVO VACCINES ASSOCIATION

Italy

EU Contribution

€ 75 320

ACADEMISCH ZIEKENHUIS LEIDEN

Netherlands

EU Contribution

€ 555 000

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU Contribution

€ 669 527,28

STICHTING WAGENINGEN RESEARCH

Netherlands

EU Contribution

€ 471 015

ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK

France

EU Contribution

€ 226 750

EATRIS ERIC

Netherlands

EU Contribution

€ 211 831,25

VACCINE FORMULATION INSTITUTE LIMITED

United Kingdom

EU Contribution

€ 670 975,22

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 640 594,85

INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA

Portugal

EU Contribution

€ 595 332,50

GENIBET - BIOPHARMACEUTICALS SA

Portugal

EU Contribution

€ 108 992,50

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH

Germany

EU Contribution

€ 402 090,85

STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER

Netherlands

EU Contribution

€ 626 813,75

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER

United Kingdom

EU Contribution

€ 130 832,50

Department of Health

United Kingdom

EU Contribution

€ 384 120

MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT

Netherlands

EU Contribution

€ 334 975,71

INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES

Spain

EU Contribution

€ 587 866,19

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

Switzerland

EU Contribution

€ 288 000

UNIVERSITE DE LAUSANNE

Switzerland

UNIVERSITA DEGLI STUDI DI SIENA

Italy

EU Contribution

€ 706 430

UNIVERSITEIT LEIDEN

Netherlands

EU Contribution

€ 212 050,21

INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE

France

EU Contribution

€ 202 283,75

INSTRUCT ACADEMIC SERVICES LIMITED

United Kingdom

EU Contribution

€ 29 260

BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE

France

EU Contribution

€ 124 031,92

Project information

Grant agreement ID: 730964

Status

Ongoing project

  • Start date

    1 May 2017

  • End date

    30 April 2022

Funded under:

H2020-EU.1.4.1.2.

  • Overall budget:

    € 10 599 993

  • EU contribution

    € 10 599 993

Coordinated by:

EUROPEAN VACCINE INITIATIVE EWIV

Germany